Search

everythinglearnresearchcommunity

for

Search:↓

The reconstructed skin model from hair follicles functions like human skin in processing chemicals and can be used to test ingredient safety.

Spanlastic nanovesicles can improve efinaconazole delivery through nails.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Tretinoin gel is safe for sun exposure, but tacalcitol doesn't significantly improve non-segmental vitiligo.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Fibroblasts from healthy donors can prevent changes seen in recessive epidermolysis bullosa simplex.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

The ethosomal formulation improved finasteride delivery through the skin.

PEA-ENL improves skin delivery and reduces inflammation without side effects.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

A man's rash caused by Finasteride improved after stopping the drug and starting new treatments.

Samcyprone ointment is effective for treating common warts if a sensitization reaction occurs first.

Adding Brij 78 to minoxidil microparticles in a certain solution helps them stick to the skin better and prevents clumping.

Rice bran extract caused moderate skin irritation but no eye irritation, while a diluted essence was not irritating to skin and only slightly to guinea pigs.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Microcapsules and effervescent tablets make insect lipids easier to consume.

Some medications caused temporary health issues that improved after stopping the drugs, but two patients died from liver problems linked to carbamazepine.

EETs can delay seizures by affecting GABA activity, offering potential new treatments for seizures.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

The new assay can help develop products for hair re-growth.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

The new drug delivery system improves exemestane's absorption and effectiveness.